Prot# M02-518: A Phase III Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Subjects with Moderate to Severely Active Psoriatic Arthritis

Project: Research project

Project Details

StatusFinished
Effective start/end date5/7/039/10/10

Funding

  • PPD Development (M02-518)
  • Abbott Laboratories (M02-518)